Life
Briefing: Political influence ‘a serious problem’ for FDA under Trump, former commissioner says
Strategic angle: Robert Califf highlights the shift towards political decision-making in the FDA during the Trump administration.
editorial-staff
1 min read
Updated 23 days ago
Robert Califf, who previously served as FDA commissioner, has indicated that political pressures have significantly altered the operational landscape of the agency.
He notes that the current administration perceives FDA decisions through a political lens, diverging from its traditional scientific and regulatory focus.
This shift raises implications for the FDA's capacity to function effectively, potentially impacting public health outcomes and regulatory integrity.